171 related articles for article (PubMed ID: 27021013)
1. Positive Role for a Negative Calcineurin Regulator in Cardiac Hypertrophy.
Gao C; Wang Y
Hypertension; 2016 May; 67(5):841-2. PubMed ID: 27021013
[No Abstract] [Full Text] [Related]
2. Cardiac-Specific EPI64C Blunts Pressure Overload-Induced Cardiac Hypertrophy.
Zhu X; Fang J; Gong J; Guo JH; Zhao GN; Ji YX; Liu HY; Wei X; Li H
Hypertension; 2016 May; 67(5):866-77. PubMed ID: 27021007
[TBL] [Abstract][Full Text] [Related]
3. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway.
Obata K; Nagata K; Iwase M; Odashima M; Nagasaka T; Izawa H; Murohara T; Yamada Y; Yokota M
Biochem Biophys Res Commun; 2005 Dec; 338(2):1299-305. PubMed ID: 16256941
[TBL] [Abstract][Full Text] [Related]
5. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
[TBL] [Abstract][Full Text] [Related]
6. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
7. Involvement of calcium-sensing receptor in cardiac hypertrophy-induced by angiotensinII through calcineurin pathway in cultured neonatal rat cardiomyocytes.
Wang LN; Wang C; Lin Y; Xi YH; Zhang WH; Zhao YJ; Li HZ; Tian Y; Lv YJ; Yang BF; Xu CQ
Biochem Biophys Res Commun; 2008 May; 369(2):584-9. PubMed ID: 18295598
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
[TBL] [Abstract][Full Text] [Related]
9. [Effects of hydrogen sulfide (H
Wu Y; Guo YY; Zhang YY; Zhang Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jan; 34(1):29-34. PubMed ID: 29926655
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy.
Dong DL; Chen C; Huo R; Wang N; Li Z; Tu YJ; Hu JT; Chu X; Huang W; Yang BF
Hypertension; 2010 Apr; 55(4):946-52. PubMed ID: 20177001
[TBL] [Abstract][Full Text] [Related]
11. The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.
Dierck F; Kuhn C; Rohr C; Hille S; Braune J; Sossalla S; Molt S; van der Ven PFM; Fürst DO; Frey N
J Biol Chem; 2017 Sep; 292(37):15180-15191. PubMed ID: 28717008
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-328 as a regulator of cardiac hypertrophy.
Li C; Li X; Gao X; Zhang R; Zhang Y; Liang H; Xu C; Du W; Zhang Y; Liu X; Ma N; Xu Z; Wang L; Chen X; Lu Y; Ju J; Yang B; Shan H
Int J Cardiol; 2014 May; 173(2):268-76. PubMed ID: 24631114
[TBL] [Abstract][Full Text] [Related]
13. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
[TBL] [Abstract][Full Text] [Related]
14. Sanggenon C protects against pressure overload‑induced cardiac hypertrophy via the calcineurin/NFAT2 pathway.
Xiao L; Gu Y; Gao L; Shangguan J; Chen Y; Zhang Y; Li L
Mol Med Rep; 2017 Oct; 16(4):5338-5346. PubMed ID: 28849031
[TBL] [Abstract][Full Text] [Related]
15. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
[TBL] [Abstract][Full Text] [Related]
16. A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
Turcotte MG; Thakur H; Kapiloff MS; Dodge-Kafka KL
J Mol Cell Cardiol; 2022 Nov; 172():26-40. PubMed ID: 35952391
[TBL] [Abstract][Full Text] [Related]
17. Activation of Serine One-Carbon Metabolism by Calcineurin Aβ1 Reduces Myocardial Hypertrophy and Improves Ventricular Function.
Padrón-Barthe L; Villalba-Orero M; Gómez-Salinero JM; Acín-Pérez R; Cogliati S; López-Olañeta M; Ortiz-Sánchez P; Bonzón-Kulichenko E; Vázquez J; García-Pavía P; Rosenthal N; Enríquez JA; Lara-Pezzi E
J Am Coll Cardiol; 2018 Feb; 71(6):654-667. PubMed ID: 29420962
[TBL] [Abstract][Full Text] [Related]
18. Vitexin protects against cardiac hypertrophy via inhibiting calcineurin and CaMKII signaling pathways.
Lu CC; Xu YQ; Wu JC; Hang PZ; Wang Y; Wang C; Wu JW; Qi JC; Zhang Y; Du ZM
Naunyn Schmiedebergs Arch Pharmacol; 2013 Aug; 386(8):747-55. PubMed ID: 23624753
[TBL] [Abstract][Full Text] [Related]
19. High-mobility group box 1 induces calcineurin-mediated cell hypertrophy in neonatal rat ventricular myocytes.
Su FF; Shi MQ; Guo WG; Liu XT; Wang HT; Lu ZF; Zheng QS
Mediators Inflamm; 2012; 2012():805149. PubMed ID: 22778498
[TBL] [Abstract][Full Text] [Related]
20. Guanosine triphosphatase activation occurs downstream of calcineurin in cardiac hypertrophy*.
Richardson KE; Tannous P; Berenji K; Nolan B; Bayless KJ; Davis GE; Rothermel BA; Hill JA
J Investig Med; 2005 Dec; 53(8):414-24. PubMed ID: 16354580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
